Future of the Animal Model Market: Strategic Analysis and Forecast to 2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Animal Model Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over recent years, there's been significant growth in the size of the animal model market. This market is forecasted to expand from $1.92 billion in 2024 to $2.09 billion in 2025, showing a compound annual growth rate (CAGR) of 9.0%. The previous growth is credited to the increasing use of animal models in biomedical research, boosted spending and significant investments in the discovery and development of drugs, a growing emphasis on precision medicine, and the wide-ranging use of animal models in the healthcare sector.

Animal Model Market Size Forecast: What's the Projected Valuation by 2029?
The market size for animal models is forecasted to experience a robust expansion in the upcoming years, predicted to climb to $2.92 billion by 2029 with a compound annual growth rate (CAGR) of 8.8%. This growth projection for the coming phase is due to reasons like genetic engineering breakthroughs, increasing emphasis on personalized medicine, escalating incidence of chronic ailments, and an upsurge in the requirement for efficient vaccines and therapies. Moreover, an increase in funding towards biomedical research also plays a part. Key trends for the future focus on enhanced demand for animal models in drug discovery and development, a surge in chronic disease incidences, and the physiological similarities between humans and animals reducing drug development time. Additionally, the escalating use of personalized medicine propelling the need for humanized mice models, coupled with the high market growth due to a rising preference for animal models in biomedical research, are also significant contributing factors.

View the full report here:
https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

What Are the Drivers Transforming the Animal Model Market?
The surge in investment activities towards pharmaceutical research and development is poised to amplify the animal model market's expansion. Mergence of innovation and science in pharmaceutical research and development paves the way for medical breakthroughs. The advent of cutting-edge therapies, the quest for treatments for complex diseases, along with stirring scientific interest and commercial prospects in healthcare sector, push the research and development process. Essential to pharmaceutical research and development, animal models forecast drug competence, safety, and harmful effects, provide understanding of biological operations, and aid in fabricating new treatments by replicating human physiological reactions and disease advancement in controlled environments. For instance, as per the data from the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade and lobbying group, the pharmaceutical research and development expenditure across Europe was at €44,500 ($47,999) in 2022 and €42,533 million ($45,877 million) in 2021 in June 2023. So, the escalating investment in pharmaceutical research and development is fuelling the growth of the animal model market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp

What Long-Term Trends Will Define the Future of the Animal Model Market?
Key players in the animal model market are concentrating on the production of inventive products like triple-immunodeficient animal models. These prototypes are vital in augmenting the precision and reliability of preclinical trials, paving the way for advanced biomedical research and facilitating novel therapeutic development for intricate human diseases. Triple-immunodeficient animal models, generally made from mice, lack three crucial components of the immune system, making them extremely useful in biomedical research, especially in human disease studies and new treatment design. For instance, Charles River Laboratories International, Inc., a US pharmaceutical company, marked the beginning of 2024 by introducing NCG mouse strains, a triple-immunodeficient mouse model for cancer research. NCG mice are inherently triple immunodeficient, lacking mature/functional T, B, and NK cells, and exhibit diminished macrophage and dendritic cell functionality. These animal prototypes can host xenograft cells, tissue and human immune components, making them perfect for research on cancer, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hemopoiesis, and tissue transplantation studies. NCG mice can also be transformed into humanized mice through engrafting PBMCs or CD34+ stem cells, thus closely replicating the human immune system.

Which Segments in the Animal Model Market Offer the Most Profit Potential?
The animal model market covered in this report is segmented -

1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types
2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies
3) By Application: Drug Discovery And Development, Basic Research, Other Applications
4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations

Subsegments:
1) By Mice: Mice, Outbred Mice, Knockout Mice, Transgenic Mice
2) By Rat: Rats, Outbred Rats, Transgenic Rats, Knockout Rats
3) By Guinea Pigs: Standard Guinea Pigs, Immunodeficient Guinea Pigs
4) By Rabbits: New Zealand White Rabbits, Dutch Belted Rabbits, Other Rabbit Breeds
5) By Hamsters: Syrian Hamsters, Chinese Hamsters
6) By Other Animal Types: Non-Human Primates (Monkeys, Chimpanzees), Dogs, Pigs, Sheep, Ferrets, Other Small Animals (Ferrets, Gerbils)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15510&type=smp

Which Firms Dominate the Animal Model Market by Market Share and Revenue in 2025?
Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd., Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd., Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.

Which Regions Offer the Highest Growth Potential in the Animal Model Market?
North America was the largest region in the animal model market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the animal model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15510

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.